GlaxoSmithKline PLC is pressing ahead with a transformation in its culture, with new emphasis on clear decision-making and a focus on "smart risk taking"already making an impact, according to Hal Barron.
The company’s chief scientific officer and president of R&D has been at the UK-headquartered firm for just under two years,...






